China-us cooperation and promote industrial development of traditional Chinese medicine - walter heilongjiang university of Chinese medicine and traditional Chinese medicine zheng metabonomics technology center

Instrument information network

 2016/01/11 17:32:34 click 219 times

[reading] walter the company recently in the 4th Chinese medicine metabolomics research peak BBS announced together with the heilongjiang university of Chinese medicine of traditional Chinese medicine of China and the United States the metabonomics technology cooperation center. The center led by heilongjiang university of Chinese medicine the vice-president professor wang xj, through party card metabonomics study of traditional Chinese medicine, promote the modernization of traditional Chinese medicine, promote the development of China's traditional Chinese medicine industry. Party card metabonomics is modernization of traditional Chinese medicine of traditional Chinese medicine research methodology in the sense of innovation, the main research of traditional Chinese medicine compound dosage form of the particularity and the corresponding specificity of curative effect.

Shanghai, China - January 11, 2016 - volt (Waters), the company recently in the 4th Chinese medicine metabolomics research peak BBS announced together with the heilongjiang university of Chinese medicine of traditional Chinese medicine of China and the United States the metabonomics technology cooperation center. The center led by heilongjiang university of Chinese medicine the vice-president professor wang xj, through party research metabolomics (Chinmedomics) syndrome of traditional Chinese medicine, promote the modernization of traditional Chinese medicine, promote the development of China's traditional Chinese medicine industry. Party card metabonomics is modernization of traditional Chinese medicine of traditional Chinese medicine research methodology in the sense of innovation, the main research of traditional Chinese medicine compound dosage form of the particularity and the corresponding specificity of curative effect.

Heilongjiang university of traditional Chinese medicine professor ChangSunZhong people with walter the company market development strategy director Phil Kilby Sir

Together for cooperation center was unveiled

Professor wang xj in the opening ceremony, said: "syndromes and prescriptions are two key scientific problems of traditional Chinese medicine, is directly related to the effectiveness of disease diagnosis and clinical treatment of traditional Chinese medicine. Traditional Chinese medicine clinical, as the formula contains a variety of pharmaceutical ingredients for symptoms of TCM clinical medication form. We cooperate with walter the company established the metabonomics technology cooperation center of traditional Chinese medicine of China and the United States, will be associated with efficacy material base for traditional Chinese medicine efficacy and safety were studied, as well as the quality problems to explore innovative drug discovery based on the clinical efficacy of traditional Chinese medicine."

Heilongjiang university of Chinese medicine vice-chancellor professor wang xj and walter market development strategy of the company director Phil Kilby Sir

Walter market development strategy of the company director Phil Mr Kilby said: "we are very honored to and heilongjiang university of Chinese medicine researchers with professor wang xj mutual cooperation in the field of research of traditional Chinese medicine. The doctor of traditional Chinese medicine of China and the United States the metabonomics technology cooperation center was established, for walter, who has the milestone significance. We hope that through the support of" TCM zheng metabolomics the forefront in the field of drug prescriptions of traditional Chinese medicine research, help promote the further implementation of Chinese medicine globalization, fight diseases and improve health for people career value."

Cooperation center was established, it is in order to effectively with metabonomics research method strategy, based on the metabolic network integrity and dynamic changes of the traditional Chinese medicine to evaluate the overall effect, reveal characteristic rules, accelerate the combination of traditional Chinese medicine and modern life science and technology, provide new opportunities for the development of traditional Chinese medicine, so as to promote the modernization of traditional Chinese medicine. Moreover, professor wang xj and heilongjiang university of Chinese medicine, the researchers will also with walter the headquarters technology center laboratory to carry out academic exchanges, and is based on walter methods conduct the thorough research to the development of the new technology.

Party card metabonomics study of traditional Chinese medicine, the need to include from sample preparation, preparation to instrumental analysis and application of a full set of laboratory analysis software solutions. At present, the party card of traditional Chinese medicine research center with many Waters Synapt G2 HDMS system, Synapt G2 - Si HDMS system, ACQUITY UPLC system, ACQUITY UPC2 system, ACQUITY TQD system, UNIFI science information system and Progenesis QI bioinformatics software.

Cooperation center is equipped with the Waters of Synapt G2 - Si HDMS system with ACQUITY UPLC system

Cooperation center is equipped with the ACQUITY UPLC system with ACQUITY UPC2 system

About the traditional Chinese medicine the metabolomics

Party card metabonomics is modernization of traditional Chinese medicine of traditional Chinese medicine research methodology in the sense of innovation, based on the particularity of traditional Chinese medicine compound dosage form and party card corresponding to the specificity of the curative effect with syndrome as a starting point, from the formula of establishing the system of associated 'evaluation of the effect of prescription - syndromes direct role in the body material analysis' methodology. Metabonomics will Chinese medicine of traditional Chinese medicine serum drug chemical and organic combination of metabonomics, on the basis of solving syndrome biomarkers, establish effective prescriptions biological evaluation system, to find and identify traditional Chinese medicine medicinal material base, associated with efficacy material base to solve quality problem such as traditional Chinese medicine efficacy and safety, and based on the innovation of traditional Chinese medicines with clinical effectiveness problem of drug discovery.

Heilongjiang university of Chinese medicine

Heilongjiang university of Chinese medicine was founded in 1954, the school is the key construction of heilongjiang province high-level university, national 973 plan project chief scientist of the unit. School is equipped with the traditional Chinese medicine, Chinese materia medica, 4 postdoctoral scientific research of combining traditional Chinese and western medicine, pharmacy, is the national first batch of the second category of characteristic points (Chinese medicine) construction and the national first class features professional (Chinese materia medica, pharmaceutical preparations, and acupuncture and massage to learn) construction points. In Chinese medicine serum drug chemical research, the natural drug efficacy material base to study Chinese medicine in the international advanced level, in traditional Chinese medicine, acupuncture prescription compatibility of the law mechanism research and treatment of internal medicine, gynecology, kidney disease and other major disease clinical research in the domestic leading level.

Heilongjiang university of Chinese medicine is located in the beautiful scenery of the northern city of Harbin, campus environment elegant, tree-lined, match well of Chinese and western architecture, unique style, teaching and the main auditorium for the elegant european-style buildings, building national protection; 21 a famous historian of Chinese medicine in ancient statue on campus as well as "the Fang Xiaodao", formed a unique culture of Chinese medicine - "big d road".

The company (www.waters.com) about walter

More than 50 years, walter, inc. (the New York stock exchange code: WAT) by providing practical, sustainable innovation, the medical service, environment management, food safety and has made significant progress in the field of global water quality monitoring, so as to create business advantages for laboratory related institutions.

As a series of separation science, laboratory information management, mass spectrum analysis and thermal analysis technology pioneer, walter the breakthrough of the technology and laboratory solutions for the success of clients to create a lasting platform.

Walter, who owns 2014 revenue of $1.99 billion, it will continue to lead the customers all over the world to explore science and remarkable achievements.

Waters, ACQUITY, ACQUITY UPLC, UPLC, Synapt, UPC2, UNIFI and Progenesis is walter the trademark of the company.